Financial Statement

Ebix, Inc. and Subsidiaries
Condensed Consolidated Balance Sheets
(In thousands, except share amounts)
  September 30, 2019 December 31, 2018
ASSETS (Unaudited)  
Current assets:    
Cash and cash equivalents $124,242 $147,766
Short-term investments 4,795 31,192
Restricted cash 18,240 8,317
Fiduciary funds- restricted 4,200 6,491
Trade accounts receivable, less allowances of $21,011 and $6,969, respectively 165,397 174,340
Other current assets 63,615 59,274
Total current assets 380,489 427,380
 
Property and equipment, net 52,597 50,294
Right-of-use assets 17,008 —
Goodwill 958,813 946,685
Intangibles, net 46,298 51,448
Indefinite-lived intangibles 42,055 42,055
Capitalized software development costs, net 13,748 11,742
Deferred tax asset, net 59,906 54,629
Other assets 34,425 26,714
Total assets $1,605,339 $1,610,947
     
LIABILITIES AND STOCKHOLDERS’ EQUITY    
Current liabilities:    
Accounts payable and accrued liabilities $117,520 $130,221
Accrued payroll and related benefits 8,683 9,227
Working capital facility 35,829 17,841
Fiduciary funds- restricted 4,200 6,491
Short-term debt 1,253 3,990
Current portion of long term debt and financing lease obligation, net of deferred financing
costs of $575		 20,203 14,603
Lease liability 5,578 —
Contingent liability for accrued earn-out acquisition consideration 1,254 13,767
Contract liabilities 27,665 35,609
Other current liabilities 31,647 85,679
Total current liabilities 253,832 317,428
 
Revolving line of credit 438,037 424,537
Long term debt and financing lease obligations, less current portion, net of deferred financing costs of $1,703 and $1,811, respectively 259,992 274,716
Other liabilities 41,126 28,287
Contingent liability for accrued earn-out acquisition consideration 9,290 11,209
Contract liabilities 7,662 9,051
Deferred tax liability, net 1,282 1,282
Lease liability 10,802 —
Total liabilities 1,022,023 1,066,510
 
Commitments and Contingencies    
 
Stockholders’ equity:    
Preferred stock, $0.10 par value, 500,000 shares authorized, no shares issued and outstanding at September 30, 2019 and December 31, 2018 — —
Series Y Convertible preferred stock, $0.10 par value, 350,000 shares authorized, no shares issued and outstanding at September 30, 2019 and no shares authorized, issue and outstanding at December 31, 2018 — —
Common stock, $0.10 par value, 220,000,000 shares authorized, 30,491,207 issued and outstanding, at September 30, 2019, and 30,567,725 issued and outstanding at December 31, 2018 3,049 3,057
Additional paid-in capital 6,208 3,397
Retained earnings 599,148 535,118
Accumulated other comprehensive loss (74,236) (63,377)
Total Ebix, Inc. stockholders’ equity 534,169 478,195
Noncontrolling interest 49,147 66,242
Total stockholders’ equity 583,316 544,437
Total liabilities and stockholders’ equity $1,605,339 $1,610,947
Investor Home

Investor Contacts

EBIX Inc
1 Ebix Way, Johns Creek, Georgia 30097
Ph: 678-281-2027 Fax: 678-281-2019

IR@ebix.com

David Collins, Tanya Kamatu, Chris Eddy
Catalyst Global - 212-924-9800 or ebix@catalyst-ir.com

Ebix Named in Fortune’s 2017 100 Fastest-Growing Companies

Follow us

   

Ebix Inc.
1 Ebix Way, Johns Creek,
GA 30097

Tel: +1 (678) 281-2020
Fax: +1 (678) 281-2019

  • Join Us

Copyright © 2022 Ebix Inc. Terms Of Use | Privacy Statement